Brown Syndrome
Symptoms, Doctors, Treatments, Advances & More

Learn About Brown Syndrome

What is the definition of Brown Syndrome?
Brown syndrome is an eye disorder characterized by abnormalities in the eye's ability to move. Specifically, the ability to look up and in is affected by a problem in the superior oblique muscle/tendon. The condition may be present at birth (congenital) or it may develop following surgery or as a result of inflammation or a problem with development. Some cases are constant while other are intermittent.
What are the alternative names for Brown Syndrome?
  • Brown syndrome
  • Superior Oblique Tendon Sheath syndrome
  • Tendon Sheath Adherence, Superior Oblique
Who are the top Brown Syndrome Local Doctors?
Elite in Brown Syndrome
Ophthalmology | Pediatrics
Elite in Brown Syndrome
Ophthalmology | Pediatrics
Referral may be required
900 Northwest 17th Street, 
Miami, FL 
Languages Spoken:
English, Spanish
Accepting New Patients

Hilda Capo is a Pediatrics provider practicing medicine in Miami, Florida. Dr. Capo is rated as an Elite provider by MediFind in the treatment of Brown Syndrome. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Strabismus, Brown Syndrome, Esotropia, Benign Essential Blepharospasm, and Tenotomy. Dr. Capo is currently accepting new patients.

Elite in Brown Syndrome
Elite in Brown Syndrome
Referral may be required

OSF Illinois Neurological Institute - Neurology

200 East Pennsylvania Avenue, 
Peoria, IL 
Languages Spoken:
English, Spanish

Jorge Kattah is a Neurologist practicing medicine in Peoria, Illinois. Dr. Kattah is rated as an Elite provider by MediFind in the treatment of Brown Syndrome. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Vertigo, Brown Syndrome, Papilledema, and Benign Paroxysmal Positional Vertigo. Dr. Kattah is board certified in American Board Of Psychiatry And Neurology.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Brown Syndrome
Elite in Brown Syndrome
Referral may be required

The Johns Hopkins Hospital

Baltimore, MD 
Languages Spoken:
English

Michael X. Repka, M.D., M.B.A., is the David L. Guyton, M.D., and Feduniak Family Professor of Ophthalmology at the Wilmer Eye Institute. He specializes in pediatric ophthalmology, strabismus, retinopathy of prematurity and pediatric neuro-ophthalmology. His clinical practice includes an interest in the management of strabismus and amblyopia. In these areas, he has a special interest in using alternatives to patching for the management of amblyopia and using strabismus surgery, botulinum toxin and adjustable sutures to treat strabismus. He also performs cataract surgery and intraocular lens implantation on children with cataracts and has a special interest in pediatric neuro-ophthalmology involving normal and abnormal visual development and the effect of injury and tumor on the visual system of the child. Dr. Repka received his M.D. degree from Thomas Jefferson University and completed his ophthalmology residency at Wills Eye Hospital. He completed fellowships in neuro-ophthalmology and pediatric ophthalmology at the Wilmer Eye Institute and joined the faculty in 1985. In addition to his clinical responsibilities, Dr. Repka is the vice chair for clinical practice at Wilmer. Dr. Repka is the past chairman of the Pediatric Eye Disease Investigator Group and past president of the Maryland Society of Eye Physicians and Surgeons. He is medical director of Government Affairs of the American Academy of Ophthalmology. Dr. Repka is rated as an Elite provider by MediFind in the treatment of Brown Syndrome. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Strabismus, Brown Syndrome, Amblyopia, Cataract Removal, and Vitrectomy. Dr. Repka is board certified in American Board Of Ophthalmology.

What are the latest Brown Syndrome Clinical Trials?
A Phase III, Randomized, Placebo-controlled, Parallel Group, Double-blind Study to Evaluate the Efficacy and Safety of NIO752 in Participants With Progressive Supranuclear Palsy Followed by an Open Label Extension

Summary: This Phase III study is intended to evaluate the efficacy and safety of NIO752 in participants with Progressive Supranuclear Palsy (PSP). Eligible participants will be randomized to receive either NIO752 or placebo followed by an open-label extension.

Match to trials
Find the right clinical trials for you in under a minute
Get started
Investigating Complex Neurodegenerative Disorders Related to Amyotrophic Lateral Sclerosis and Frontotemporal Dementia

Background: Neurodegenerative disorders can lead to problems in movement or memory. Some can cause abnormal proteins to build up in brain cells. Researchers want to understand whether these diseases have related causes or risk factors.

Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center